利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

19 条记录 (耗时 0.017 秒)

    Forward direction power control method using backward direction power control sub-channel for mobile communication system
    1.
    发明授权
    Forward direction power control method using backward direction power control sub-channel for mobile communication system 失效
    使用反向功率控制子信道进行移动通信系统的正向功率控制方法

    公开(公告)号：US06781966B1

    公开(公告)日：2004-08-24

    申请号：US09643496

    申请日：2000-08-22

    申请人： Jin Sook Kim

    发明人： Jin Sook Kim

    IPC分类号： H04B700

    CPC分类号： H04W52/12 ,  H04W52/08 ,  H04W52/20

    摘要： In the present invention, a forward direction power control method using a backward direction power control sub-channel for a mobile communication system is disclosed. The method according to the present invention is directed to rapidly and effectively controlling the power of a base station transmission signal using a power control, sub-channel in a backward direction pilot channel when performing an outer loop and inner loop in a mobile station of a mobile communication system which adapts an IS-2000 CDMA method and rapidly coping with a channel environment and forward direction wireless environment for thereby decreasing the power of a transmission signal of the base station and increasing the capacity of the system.

    摘要翻译： 在本发明中，公开了使用移动通信系统的反向功率控制子信道的正向功率控制方法。 根据本发明的方法涉及使用功率控制功能来快速有效地控制基站传输信号的功率，当执行外部环路的移动台中的外部环路和内部环路时，在向后导频信道中的子信道 移动通信系统，其适应IS-2000 CDMA方法，并且快速应对信道环境和前向无线环境，从而降低基站的传输信号的功率并增加系统的容量。

    COMPOSITIONS AND FUNCTIONAL FOODS FOR TREATING AND PREVENTING OBESITY USING POLYGONUM CUSPIDATUM BUTANOL FRACTION AND ETHYL ACETATE FRACTION
    2.
    发明申请
    COMPOSITIONS AND FUNCTIONAL FOODS FOR TREATING AND PREVENTING OBESITY USING POLYGONUM CUSPIDATUM BUTANOL FRACTION AND ETHYL ACETATE FRACTION 有权
    组合物和功能性食品，用于处理和预防使用多酚丁醇脂肪酸酯和乙酸乙酯酯的成分

    公开(公告)号：US20120183633A1

    公开(公告)日：2012-07-19

    申请号：US13498247

    申请日：2009-12-29

    申请人： Jin Sook Kim ,  Dae Sik Jang ,  Young Sook Kim ,  Junghyun Kim ,  Chan-Sik Kim

    发明人： Jin Sook Kim ,  Dae Sik Jang ,  Young Sook Kim ,  Junghyun Kim ,  Chan-Sik Kim

    IPC分类号： A61K36/704 ,  A61P3/06 ,  A61P3/00 ,  A61P3/04

    CPC分类号： A61K36/704 ,  A23L33/105

    摘要： The present invention relates to the obesity-curative or obesity-preventive effect of a Polygonum cuspidatum butanol fraction and a Polygonum cuspidatum ethylacetate fraction, and more particularly, to a pharmaceutical composition and a functional food for treating obesity, the pharmaceutical composition and the functional food comprising a Polygonum cuspidatum butanol fraction (POCU-1b) and an ethylacetate fraction as active ingredients, wherein the Polygonum cuspidatum butanol fraction and the ethylacetate fraction inhibit effectively the activity of pancreatic lipase, an important enzyme involving in fat absorption in a living body, and have excellent inhibitory effect on fat absorption in the short term fat absorption-inhibitory animal experiments using lipid emulsions.

    摘要翻译： 本发明涉及枸杞子枸杞子和枸杞子乙酸乙酯级分的肥胖治疗或肥胖预防效果，更具体地说，涉及用于治疗肥胖症的药物组合物和功能性食品，药物组合物和功能性食品 包括枸杞子丁醇级分（POCU-1b）和乙酸乙酯级分作为活性成分，其中枸杞子丁醇级分和乙酸乙酯级分有效地抑制了胰脂肪酶的活性，胰脂肪酶是涉及活体脂肪吸收的重要酶， 在使用脂质乳剂的短期脂肪吸收抑制动物实验中对脂肪吸收具有优异的抑制作用。

    Combined use of cell permeable Nanog and Oct4 for increasing self-renewal and suppressing differentiation of stem cells
    3.
    发明授权
    Combined use of cell permeable Nanog and Oct4 for increasing self-renewal and suppressing differentiation of stem cells 有权
    结合使用细胞渗透性Nanog和Oct4来增加自我更新和抑制干细胞分化

    公开(公告)号：US08158415B2

    公开(公告)日：2012-04-17

    申请号：US12528919

    申请日：2008-02-27

    申请人： Dae Woong Jo ,  Jin Sook Kim ,  Yun Kyung Park

    发明人： Dae Woong Jo ,  Jin Sook Kim ,  Yun Kyung Park

    IPC分类号： C12N15/00 ,  C07H21/02 ,  C07K14/00

    CPC分类号： C07K14/4702

    摘要： The present invention discloses cell permeable Nanog and Oct4 recombinant proteins that comprise a kaposi fibroblast growth factor 4 (kFGF4)-derived macromolecule transduction domain (MTD). Also disclosed are polynucleotides encoding the cell permeable Nanog and Oct4 recombinant proteins, a method of increasing self-renewal and suppressing differentiation of stem cells by treating the cells in combination with the cell permeable Nanog and Oct4 recombinant proteins, and the combined use of the cell permeable Nanog and Oct4 recombinant proteins for increasing self-renewal and suppressing differentiation of stem cells.

    摘要翻译： 本发明公开了包含kaposi成纤维细胞生长因子4（kFGF4）衍生的大分子转导结构域（MTD）的细胞渗透性Nanog和Oct4重组蛋白。 还公开了编码细胞渗透性Nanog和Oct4重组蛋白的多核苷酸，通过与细胞渗透性Nanog和Oct4重组蛋白组合处理细胞，增加自我更新和抑制干细胞分化的方法，以及细胞的组合使用 可渗透的Nanog和Oct4重组蛋白，用于增强自我更新和抑制干细胞的分化。

    Compositions and functional foods for treating and preventing obesity using polygonum cuspidatum butanol fraction and ethyl acetate fraction
    4.
    发明授权
    Compositions and functional foods for treating and preventing obesity using polygonum cuspidatum butanol fraction and ethyl acetate fraction 有权
    用于治疗和预防肥胖的组合物和功能性食物，使用枸杞子丁醇部分和乙酸乙酯部分

    公开(公告)号：US09504725B2

    公开(公告)日：2016-11-29

    申请号：US13498247

    申请日：2009-12-29

    申请人： Jin Sook Kim ,  Dae Sik Jang ,  Young Sook Kim ,  Junghyun Kim ,  Chan-Sik Kim

    发明人： Jin Sook Kim ,  Dae Sik Jang ,  Young Sook Kim ,  Junghyun Kim ,  Chan-Sik Kim

    IPC分类号： A61K36/704

    CPC分类号： A61K36/704 ,  A23L33/105

    摘要： The present invention relates to the obesity-curative or obesity-preventive effect of a Polygonum cuspidatum butanol fraction and a Polygonum cuspidatum ethylacetate fraction, and more particularly, to a pharmaceutical composition and a functional food for treating obesity, the pharmaceutical composition and the functional food comprising a Polygonum cuspidatum butanol fraction (POCU-1b) and an ethylacetate fraction as active ingredients, wherein the Polygonum cuspidatum butanol fraction and the ethylacetate fraction inhibit effectively the activity of pancreatic lipase, an important enzyme involving in fat absorption in a living body, and have excellent inhibitory effect on fat absorption in the short term fat absorption-inhibitory animal experiments using lipid emulsions.

    摘要翻译： 本发明涉及枸杞子枸杞子和枸杞子乙酸乙酯级分的肥胖治疗或肥胖预防效果，更具体地说，涉及用于治疗肥胖症的药物组合物和功能性食品，药物组合物和功能性食品 包括枸杞子丁醇级分（POCU-1b）和乙酸乙酯级分作为活性成分，其中枸杞子丁醇级分和乙酸乙酯级分有效地抑制了胰脂肪酶的活性，胰脂肪酶是涉及活体脂肪吸收的重要酶， 在使用脂质乳剂的短期脂肪吸收抑制动物实验中对脂肪吸收具有优异的抑制作用。